Why Illumina Rose 18.7% in August

Shares of Illumina (NASDAQ: ILMN), a leading manufacturer of genetic testing equipment, rose 18.7% in August, according to data from S&P Global Market Intelligence. Investors can thank solid second-quarter results and bullish guidance for the big jump.

Here's a review of the key takeaways from the company's impressive second quarter:

Given the estimate topping results and bullish revenue guidance, it isn't hard to figure out why shareholders had a great month.

Source: Fool.com